PL Planet Labs PBC
Price Chart
Executive Summary
Planet Labs filed a 424B5 prospectus supplement for an at-the-market (ATM) equity offering of up to $1.5 billion in Class A common stock, with the option to use range forward sale agreements. The filing comes one day after strong Q1 FY2027 earnings (revenue +42% YoY, raised guidance) and concurrent with a shelf registration, signaling opportunistic capital raising rather than distress. The massive potential dilution (~10% of market cap at current price) is the dominant bearish factor, though the strong operational momentum and cash from warrant redemptions ($108M) partially offset the overhang.
Actionable Insight
The $1.5B ATM creates significant near-term overhang. Monitor daily trading volumes for actual share sales — the filing does not commit to any minimum. If the stock holds above $43.53 despite the overhang, it signals strong demand absorbing supply. The range forward structure may mute immediate selling pressure but adds complexity. Watch for any 8-K reporting initial takedown amounts.
Key Facts
- Up to $1.5 billion of Class A common stock may be sold via ATM offering or range forward transactions.
- Offering size represents ~10% of Planet Labs' $15.5B market cap at the $43.53 reference price.
- Filed one day after Q1 FY2027 earnings: revenue $94.2M (+42% YoY), raised FY2027 guidance to $425M-$441M.
- Net tangible book value per share would increase from $0.83 to $4.78, but new investors face $38.75 dilution per share at the assumed price.
- Commissions to sales agents capped at 2.0% of gross proceeds; forward sellers may receive up to 2.0% commission.
- Range forward transactions allow the company to hedge dilution timing but introduce counterparty risk and potential price caps/floors.
- Proceeds intended for growth, potential acquisitions, and general corporate purposes.
- Cross-filing context: S-3ASR shelf filed same day; earnings 8-K filed 1 day prior with bullish results.
Financial Impact
Up to $1.5 billion in potential equity issuance, representing ~10% of market cap. At $43.53/share, this would add ~34.5M shares (10.4% dilution to existing holders). Net proceeds after ~2% commissions would be ~$1.47B.
Risk Factors
- Massive dilution: up to 10.4% share count increase at current prices.
- ATM sales at variable prices could depress the stock over time.
- Range forward transactions introduce counterparty risk with Goldman Sachs and Citibank.
- Early termination provisions in range forwards could force unfavorable settlements.
- Broad discretion in use of proceeds may lead to value-destructive acquisitions.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001140361-26-024104 |
| Document: ny20075555x2_ex107.htm | 0001140361-26-024104 |
| Document: 0001140361-26-024104-index-headers.html | 0001140361-26-024104 |
| Document: 0001140361-26-024104-index.html | 0001140361-26-024104 |
| Document: 0001140361-26-024104.txt | 0001140361-26-024104 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $31.77 awaiting T+1 | awaiting T+1 | — | $31.15 (−1.95%) |
|
Jun 5, 2026
9d ago
|
8-K
| $39.95 awaiting T+1 | awaiting T+1 | — | $31.15 (+22.03%) |
|
Jun 5, 2026
9d ago
|
424B5
| $41.56 awaiting T+1 | awaiting T+1 | — | $31.15 (+25.05%) |
|
Jun 5, 2026
9d ago
|
S-3ASR
| $42.50 awaiting T+1 | awaiting T+1 | — | $31.15 (−26.71%) |
|
Jun 5, 2026
9d ago
|
10-K/A
| $41.50 awaiting T+1 | awaiting T+1 | — | $31.15 (−24.94%) |
|
Jun 4, 2026
10d ago
|
8-K
| $44.97 awaiting T+1 | awaiting T+1 | — | $31.15 (−30.73%) |
|
May 29, 2026
16d ago
|
DEFA14A
| $51.14 $46.46 | ▼ −9.15% | ▼ −9.43% | $31.15 (−39.09%) |
|
May 4, 2026
5w ago
|
8-K
| $37.13 $39.69 | ▲ +6.89% | ▲ +5.51% | $31.15 (−16.11%) |
|
Apr 27, 2026
6w ago
|
25-NSE
| $23.71 $23.71 | · 0.00% | ▲ +0.49% | $31.15 (+31.38%) |
|
Apr 15, 2026
8w ago
|
144
| — | awaiting T+1 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access